4.8 Letter

PATHWAY-2: spironolactone for resistant hypertension Reply

Journal

LANCET
Volume 387, Issue 10026, Pages 1373-1374

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/S0140-6736(16)00698-X

Keywords

-

Funding

  1. Medical Research Council [MC_PC_13090] Funding Source: Medline
  2. MRC [MC_PC_13090] Funding Source: UKRI
  3. Medical Research Council [MC_PC_13090] Funding Source: researchfish
  4. National Institute for Health Research [NF-SI-0512-10052, NF-SI-0514-10011, NF-SI-0509-10222] Funding Source: researchfish

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available